Home Merck, Ferring Pharmaceuticals and the World Health Organization Working Together to Prevent Excessive Bleeding in Women after Childbirth
 

Keywords :   


Merck, Ferring Pharmaceuticals and the World Health Organization Working Together to Prevent Excessive Bleeding in Women after Childbirth

2014-04-04 14:00:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. Post-partum Hemorrhage Is Leading Cause of Mothers Dying WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Ferring Pharmaceuticals today announced their collaboration with the World Health Organization (WHO) to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding (post-partum hemorrhage) in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates (ICH climatic zone IV). Language: English Contact: MerckMedia:Jennifer Allen Woodruff, 267-305- 3550orLainie Keller, 908-423-4187orInvestor:Carol Ferguson, 908-423-4465orFerring Media:Helen Gallagher, +41 58 301 0051orPatrick Gorman, +41 58 301 0053 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: world health working women

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »